SEMA3B and esophageal squamous cell carcinoma: It has been reported that SEMA3B-AS1 was deemed as a novel cancer suppressor in gastric cardia adenocarcinoma, esophageal squamous cell carcinoma, and hepatocellular carcinoma (37–39).